Cargando…
A benefit–risk assessment model for statins using multicriteria decision analysis based on a discrete choice experiment in Korean patients
PURPOSE: The benefit–risk balance for drugs can alter post approval owing to additional data on efficacy or adverse events. This study developed a quantitative benefit–risk assessment (BRA) model for statins using multicriteria decision analysis with discrete choice experiments and compared a recent...
Autores principales: | Byun, Ji-Hye, Kwon, Sun-Hong, Ha, Ji-Hye, Lee, Eui-Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912313/ https://www.ncbi.nlm.nih.gov/pubmed/27358567 http://dx.doi.org/10.2147/TCRM.S100438 |
Ejemplares similares
-
Comparison of benefit–risk preferences of patients and physicians regarding cyclooxygenase-2 inhibitors using discrete choice experiments
por: Byun, Ji-Hye, et al.
Publicado: (2016) -
Benefit–risk assessment of HMG-CoA reductase inhibitors (statins): a discrete choice experiment
por: Wanishayakorn, Tanatape, et al.
Publicado: (2016) -
Multicriteria methodology for decision aiding
por: Roy, Bernard
Publicado: (1996) -
Multicriteria decision making and differential
por: Leitmann, George
Publicado: (1976) -
Quantitative Benefit–Risk Assessment of COVID-19 Vaccines Using the Multi-Criteria Decision Analysis
por: Son, Kyung-Hwa, et al.
Publicado: (2022)